The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Jan. 30, 2020
Applicant:

Women & Infants Hospital of Rhode Island, Providence, RI (US);

Inventors:

Surendra Sharma, Warwick, RI (US);

Satyan Kalkunte, Frisco, TX (US);

Udo Jeschke, Munich, DE;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/76 (2006.01); G01N 33/68 (2006.01); A61K 38/24 (2006.01);
U.S. Cl.
CPC ...
G01N 33/76 (2013.01); A61K 38/24 (2013.01); G01N 33/689 (2013.01); G01N 2400/10 (2013.01); G01N 2440/38 (2013.01); G01N 2800/368 (2013.01);
Abstract

Disclosed herein is a method of identifying and/or addressing incipient preeclampsia in a patient-subject by the steps of (a) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a said patient-subject at about 25 weeks of pregnancy or earlier; (b) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a pregnant non-preeclampsia one or more subjects at about 30 weeks of pregnancy or later, wherein said at least one sialyl Lewis antigen assay is for a sialyl Lewis antigen assayed in step (a) is and if more than one subject is assayed, averaging said results; and (c) managing said patient-subject for preeclampsia, if said level of at least one sialyl Lewis antigen of step (a) is at or greater than about 20% above the level of such sialyl Lewis antigen assayed in step (b).


Find Patent Forward Citations

Loading…